ATE170560T1 - Metalloproteinase-inhibitoren - Google Patents
Metalloproteinase-inhibitorenInfo
- Publication number
- ATE170560T1 ATE170560T1 AT90305433T AT90305433T ATE170560T1 AT E170560 T1 ATE170560 T1 AT E170560T1 AT 90305433 T AT90305433 T AT 90305433T AT 90305433 T AT90305433 T AT 90305433T AT E170560 T1 ATE170560 T1 AT E170560T1
- Authority
- AT
- Austria
- Prior art keywords
- metalloproteinase inhibitors
- disclosed
- methods
- metalloproteinase
- analogs
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
- C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/81—Protease inhibitors
- C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
- C07K14/8146—Metalloprotease (E.C. 3.4.24) inhibitors, e.g. tissue inhibitor of metallo proteinase, TIMP
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/38—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against protease inhibitors of peptide structure
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/70—Vectors or expression systems specially adapted for E. coli
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2800/00—Nucleic acids vectors
- C12N2800/10—Plasmid DNA
- C12N2800/108—Plasmid DNA episomal vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2840/00—Vectors comprising a special translation-regulating system
- C12N2840/44—Vectors comprising a special translation-regulating system being a specific part of the splice mechanism, e.g. donor, acceptor
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Mycology (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Lubricants (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US07/355,027 US7994136B1 (en) | 1989-05-19 | 1989-05-19 | Metalloproteinase inhibitor |
| US50190490A | 1990-03-29 | 1990-03-29 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE170560T1 true ATE170560T1 (de) | 1998-09-15 |
Family
ID=26998675
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT90305433T ATE170560T1 (de) | 1989-05-19 | 1990-05-18 | Metalloproteinase-inhibitoren |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US6946264B1 (de) |
| EP (2) | EP0623676A1 (de) |
| JP (1) | JP2877509B2 (de) |
| AT (1) | ATE170560T1 (de) |
| AU (1) | AU648505B2 (de) |
| CA (1) | CA2017166C (de) |
| DE (1) | DE69032609T2 (de) |
| DK (1) | DK0398753T3 (de) |
| ES (1) | ES2123495T3 (de) |
| SG (2) | SG43824A1 (de) |
| WO (1) | WO1990014363A1 (de) |
Families Citing this family (89)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5714465A (en) * | 1989-05-19 | 1998-02-03 | Amgen Inc. | Method of inhibiting tumor cell dissemination with a metalloproteinase inhibitor |
| US5180820A (en) * | 1989-08-30 | 1993-01-19 | Barde Yves Alain | Brain-derived neurotrophic factor |
| US7217689B1 (en) | 1989-10-13 | 2007-05-15 | Amgen Inc. | Glycosylation analogs of erythropoietin |
| US5389529A (en) * | 1991-06-12 | 1995-02-14 | Regeneron Pharmaceuticals, Inc. | Modified lamβ signal sequence and processes for producing recombinant neurotrophins |
| JP3017591B2 (ja) | 1992-01-17 | 2000-03-13 | 富士薬品工業株式会社 | 抗ヒトｔｉｍｐ−２モノクローナル抗体の製法およびその利用 |
| CA2164498C (en) * | 1993-07-09 | 2007-09-11 | Paul A. Price | Assay for ykl-40 as a marker for degradation of mammalian connective tissue matrices |
| CA2472404A1 (en) * | 1993-07-19 | 1995-02-02 | Angiotech Pharmaceuticals, Inc. | Combination of stent and anti-angiogenic factor |
| US6562596B1 (en) | 1993-10-06 | 2003-05-13 | Amgen Inc. | Tissue inhibitor of metalloproteinase type three (TIMP-3) composition and methods |
| US5840698A (en) * | 1994-10-27 | 1998-11-24 | Affymax Technologies N.V. | Inhibitors of collagenase-1 and stormelysin-I metalloproteases, pharmaceutical compositions comprising same and methods of their use |
| US5831004A (en) * | 1994-10-27 | 1998-11-03 | Affymax Technologies N.V. | Inhibitors of metalloproteases, pharmaceutical compositions comprising same and methods of their use |
| US6544761B2 (en) | 1994-12-13 | 2003-04-08 | Human Genome Sciences, Inc. | Human tissue inhibitor of metalloproteinase-4 |
| ES2281898T3 (es) * | 1994-12-13 | 2007-10-01 | Human Genome Sciences, Inc. | Inhibidor tisular humano de metaloproteinasa-4. |
| US6057124A (en) * | 1995-01-27 | 2000-05-02 | Amgen Inc. | Nucleic acids encoding ligands for HEK4 receptors |
| IL117175A (en) | 1995-02-20 | 2005-11-20 | Sankyo Co | Osteoclastogenesis inhibitory factor protein |
| US6184200B1 (en) | 1995-09-28 | 2001-02-06 | Amgen Inc. | Truncated glial cell line-derived neurotrophic factor |
| US7632922B1 (en) | 1995-12-22 | 2009-12-15 | Amgen, Inc. | Osteoprotegerin |
| US6369027B1 (en) | 1995-12-22 | 2002-04-09 | Amgen Inc. | Osteoprotegerin |
| US7138251B1 (en) | 1996-04-22 | 2006-11-21 | Amgen Inc. | Polynucleotides encoding a neurotrophic factor receptor |
| US6455277B1 (en) | 1996-04-22 | 2002-09-24 | Amgen Inc. | Polynucleotides encoding human glial cell line-derived neurotrophic factor receptor polypeptides |
| JP2001508648A (ja) | 1996-11-06 | 2001-07-03 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア | 腫瘍壊死因子レセプター放出酵素、酵素を含む組成物、およびその使用方法 |
| DE69740107D1 (de) | 1996-12-23 | 2011-03-10 | Immunex Corp | Rezeptor aktivator von nf-kappa b, rezeptor is mitglied der tnf rezeptor superfamilie |
| ES2263204T5 (es) | 1997-04-15 | 2013-10-14 | Daiichi Sankyo Company, Limited | Nueva proteína y proceso para producir la misma |
| US5843678A (en) * | 1997-04-16 | 1998-12-01 | Amgen Inc. | Osteoprotegerin binding proteins |
| US6316408B1 (en) | 1997-04-16 | 2001-11-13 | Amgen Inc. | Methods of use for osetoprotegerin binding protein receptors |
| JP2001525669A (ja) * | 1997-05-12 | 2001-12-11 | ネーデルランセ オルハニサチエ フォール トゥーヘパスト−ナツールウェーテンシャッペルック オンデルズク テーエヌオー | 細胞遊走の阻害のための方法および構築物 |
| US6790823B1 (en) | 1998-04-23 | 2004-09-14 | Amgen Inc. | Compositions and methods for the prevention and treatment of cardiovascular diseases |
| US7304150B1 (en) | 1998-10-23 | 2007-12-04 | Amgen Inc. | Methods and compositions for the prevention and treatment of anemia |
| JP4342027B2 (ja) | 1999-04-01 | 2009-10-14 | オリエンタル酵母工業株式会社 | Ｔｉｍｐ修飾体 |
| US7459540B1 (en) | 1999-09-07 | 2008-12-02 | Amgen Inc. | Fibroblast growth factor-like polypeptides |
| US20030103978A1 (en) | 2000-02-23 | 2003-06-05 | Amgen Inc. | Selective binding agents of osteoprotegerin binding protein |
| WO2001063294A2 (en) * | 2000-02-24 | 2001-08-30 | Oxford Glycosciences (Uk) Limited | Diagnosis of bipolar affective disorder (bad) and unipolar depression |
| US7514239B2 (en) | 2000-03-28 | 2009-04-07 | Amgen Inc. | Nucleic acid molecules encoding beta-like glycoprotein hormone polypeptides and heterodimers thereof |
| JP4939715B2 (ja) * | 2000-04-05 | 2012-05-30 | イーペーエフ ファルマシューティカルス ゲゼルシャフト ミット ベシュレンクテル ハフツング | 骨合成代謝活性物質として金属プロテイナーゼ−２（ｔｉｍｐ−２）の組織阻害剤を含む薬剤 |
| ES2391124T3 (es) | 2000-06-28 | 2012-11-21 | Amgen Inc. | Moléculas de receptor de linfopoyetina estromal tímica y usos de las mismas |
| EP1174129A1 (de) * | 2000-07-17 | 2002-01-23 | Zenner, Hans Peter, Prof. Dr. med. | Verwendung eines Matrix-Metalloproteinase-Inhibitors zur Behandlung von Krebs |
| EP2295081B1 (de) | 2001-06-26 | 2018-10-31 | Amgen Inc. | Antikörper gegen OPGL |
| US7718776B2 (en) | 2002-04-05 | 2010-05-18 | Amgen Inc. | Human anti-OPGL neutralizing antibodies as selective OPGL pathway inhibitors |
| ES2290449T3 (es) | 2002-04-09 | 2008-02-16 | Sanofi Pasteur Limited | Acido nucleico de cea modificado y vectores de expresion. |
| AUPS282002A0 (en) * | 2002-06-06 | 2002-06-27 | Gropep Limited | Metalloproteinase inhibitors |
| KR101317045B1 (ko) | 2002-09-06 | 2013-10-16 | 암젠 인코포레이티드 | 치료학적 인체 항-ｉｌ-1ｒ1 모노클로날 항체 |
| WO2004034988A2 (en) | 2002-10-16 | 2004-04-29 | Amgen Inc. | Human anti-ifn-ϝ neutralizing antibodies as selective ifn-ϝ pathway inhibitors |
| TWI476206B (zh) | 2003-07-18 | 2015-03-11 | Amgen Inc | 對肝細胞生長因子具專一性之結合劑 |
| ME00226B (me) | 2004-07-15 | 2011-02-10 | Medarex Llc | Humana anti-ngf neutrališuća antitijela kao selektivni inhibitori ngf signalne kaskade |
| MY146381A (en) | 2004-12-22 | 2012-08-15 | Amgen Inc | Compositions and methods relating relating to anti-igf-1 receptor antibodies |
| PA8660701A1 (es) | 2005-02-04 | 2006-09-22 | Pfizer Prod Inc | Agonistas de pyy y sus usos |
| US7629315B2 (en) | 2005-03-09 | 2009-12-08 | University Of Pittsburgh Of The Commonwealth System Of Higher Education | Compositions for blocking the inhibitory effect of human CRP on human leptin |
| HUE029021T2 (en) | 2005-06-21 | 2017-02-28 | Xoma (Us) Llc | IL-1beta-binding antibodies and fragments thereof |
| EP2397498A3 (de) | 2005-07-18 | 2013-11-27 | Amgen, Inc | Humane Anti-B7RP1-neutralisierende Antikörper |
| TW200736277A (en) | 2005-11-14 | 2007-10-01 | Amgen Inc | RANKL antibody-PTH/PTHrP chimeric molecules |
| CN101511868B (zh) | 2006-07-24 | 2013-03-06 | 比奥雷克西斯制药公司 | 毒蜥外泌肽融合蛋白 |
| US7947646B2 (en) | 2007-03-06 | 2011-05-24 | Amgen Inc. | Variant activin receptor polypeptides |
| JP5611222B2 (ja) | 2008-11-26 | 2014-10-22 | アムジエン・インコーポレーテツド | アクチビンｉｉｂ受容体ポリペプチドの変異体及びその使用 |
| MX2011006922A (es) | 2008-12-24 | 2012-06-12 | Netherlands Vaccine Inst | Polipeptidos de neumolisina (ply) modificada a partir de streptococcus pneumonia. |
| US20140093556A1 (en) | 2011-01-28 | 2014-04-03 | Sanofi Pasteur Sa | Immunological Compositions Against HIV |
| MX2013008833A (es) | 2011-02-02 | 2013-12-06 | Amgen Inc | Metodos y composiciones relacionadas con la inhibicion de receptor del factor de crecimiento similar a la insulina 1 (igf-1r). |
| BR112014002817A2 (pt) | 2011-08-08 | 2021-09-08 | Curelab Oncology Inc | Uso de um polipeptídeo p62, ou de um ácido nucleico que codifica p62 |
| DK178233B1 (en) | 2012-09-17 | 2015-09-14 | Novartis Tiergesundheit Ag | Fiskevaccine |
| WO2014070975A1 (en) | 2012-11-02 | 2014-05-08 | Novartis Ag | Flavivirus associated with theiler's disease |
| AU2014212014A1 (en) | 2013-02-01 | 2015-08-27 | Amgen Inc. | Administration of an anti-activin-A compound to a subject |
| PH12022550138A1 (en) | 2013-03-13 | 2023-03-06 | Amgen Inc | Proteins specific for baff and b7rp1 and uses thereof |
| US9458246B2 (en) | 2013-03-13 | 2016-10-04 | Amgen Inc. | Proteins specific for BAFF and B7RP1 |
| WO2014140938A2 (en) | 2013-03-14 | 2014-09-18 | Centre Hospitalier Universitaire Vaudois | Immunological methods |
| AU2014369861B2 (en) | 2013-12-29 | 2018-09-13 | Curelab Oncology, Inc. | Methods and compositions relating to p62/SQSTM1 for the treatment and prevention of inflammation-associated diseases |
| US10571468B2 (en) | 2014-05-09 | 2020-02-25 | One Lambda, Inc. | Modified Fc gamma receptor type III (FCγIII, HNA-1) polypeptides and the uses thereof |
| PE20170471A1 (es) | 2014-06-13 | 2017-05-14 | Santa Maria Biotherapeutics Inc | Polipeptidos receptores formulados y metodos relacionados |
| KR102357893B1 (ko) | 2014-08-05 | 2022-02-04 | 맵퀘스트 에스아 | Pd-1 에 결합하는 면역학적 시약 |
| CA2983440C (en) | 2015-04-22 | 2024-03-12 | Alivegen Usa Inc. | Novel hybrid actriib ligand trap proteins for treating muscle wasting diseases |
| US20170082619A1 (en) | 2015-09-23 | 2017-03-23 | One Lambda, Inc. | Methods of Detecting Alloantibodies Using HLA and Non-HLA Antigens |
| CA3045756A1 (en) | 2015-12-05 | 2017-06-08 | Centre Hospitalier Universitaire Vaudois | Hiv binding agents |
| ES3034233T3 (en) | 2016-01-22 | 2025-08-14 | MabQuest SA | Non-blocking pd1 specific antibodies |
| JOP20190085A1 (ar) | 2016-10-20 | 2019-04-17 | Biogen Ma Inc | طرق علاج الضمور العضلي ومرض العظام باستخدام بروتينات احتجاز مركب ترابطي actriib هجين حديثة |
| GB201710973D0 (en) | 2017-07-07 | 2017-08-23 | Avacta Life Sciences Ltd | Scaffold proteins |
| KR20250156190A (ko) | 2018-06-22 | 2025-10-31 | 큐진 인크. | 인터루킨-2 변이체 및 이의 사용 방법 |
| WO2020012435A1 (en) | 2018-07-13 | 2020-01-16 | Lausanne University Hospital | Hiv binding agents |
| US20200072831A1 (en) | 2018-08-23 | 2020-03-05 | Emory University | Methods of detecting alloantibodies to hla class ii antigens |
| US20220267416A1 (en) | 2019-07-15 | 2022-08-25 | Lausanne University Hospital | Hiv binding agents |
| WO2021074695A1 (en) | 2019-10-16 | 2021-04-22 | Avacta Life Sciences Limited | PD-L1 INHIBITOR - TGFβ INHIBITOR BISPECIFIC DRUG MOIETIES. |
| GB202101299D0 (en) | 2020-06-09 | 2021-03-17 | Avacta Life Sciences Ltd | Diagnostic polypetides and methods |
| TWI884296B (zh) | 2020-08-11 | 2025-05-21 | 美商碩騰服務公司 | 抗冠狀病毒疫苗 |
| CN114315985A (zh) | 2020-09-29 | 2022-04-12 | 硕腾服务有限责任公司 | 减毒猪流行性腹泻病毒 |
| WO2022234003A1 (en) | 2021-05-07 | 2022-11-10 | Avacta Life Sciences Limited | Cd33 binding polypeptides with stefin a protein |
| US20240390476A1 (en) | 2021-08-31 | 2024-11-28 | Zoetis Services Llc | Attenuated alphavirus |
| EP4413038A1 (de) | 2021-10-07 | 2024-08-14 | Avacta Life Sciences Limited | Pd-l1-bindende affimere |
| US20240409638A1 (en) | 2021-10-07 | 2024-12-12 | Avacta Life Sciences Limited | Serum half-life extended pd-l1 binding polypeptides |
| US20250041385A1 (en) | 2021-12-10 | 2025-02-06 | Biogen Ma Inc. | Modified actrii proteins and methods of use thereof |
| CN119213021A (zh) | 2022-02-10 | 2024-12-27 | 艾菲赛尔治疗株式会社 | 与CD40L特异性结合的Stefin A蛋白变体及其用途 |
| WO2023218243A1 (en) | 2022-05-12 | 2023-11-16 | Avacta Life Sciences Limited | Lag-3/pd-l1 binding fusion proteins |
| CN121013863A (zh) | 2023-03-31 | 2025-11-25 | 艾菲赛尔治疗株式会社 | Tnfr2结合多肽及使用方法 |
| FR3147278A1 (fr) | 2023-03-31 | 2024-10-04 | Avacta Life Sciences Limited | Polypeptides de liaison au tnfr2 et procedes d'utilisation |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6936694B1 (en) | 1982-05-06 | 2005-08-30 | Intermune, Inc. | Manufacture and expression of large structural genes |
| US4710473A (en) | 1983-08-10 | 1987-12-01 | Amgen, Inc. | DNA plasmids |
| EP0188312A3 (de) * | 1985-01-07 | 1988-01-13 | Celltech Limited | Verfahren zur Herstellung eines Proteins |
| EP0189784B1 (de) * | 1985-01-18 | 1989-11-08 | G.D. Searle & Co. | Menschlicher, natürlicher Collagenaseninhibitor |
| KR940010862B1 (ko) * | 1985-02-05 | 1994-11-18 | 씨네겐 바이오로지칼즈, 인코포레이티드 | 유용한 메탈로프로테이나제 억제제 씨퀀스 재조합 벡터계의 제조를 위한 dna 재조합 방법 |
| JP2609858B2 (ja) * | 1987-02-27 | 1997-05-14 | 富士薬品工業 株式会社 | コラゲナーゼインヒビターの酵素免疫学的定量法 |
| AU634533B2 (en) * | 1989-03-21 | 1993-02-25 | United States of America, as represented by the Secretary, U.S. Department of Commerce, The | Matrix metalloproteinase inhibitor peptides |
| DE69011433T2 (de) * | 1989-05-26 | 1995-04-06 | Univ Washington | Gewebeinhibitor für Metalloproteasen (TIMP-2). |
-
1990
- 1990-05-10 JP JP2507615A patent/JP2877509B2/ja not_active Expired - Lifetime
- 1990-05-10 AU AU56388/90A patent/AU648505B2/en not_active Expired
- 1990-05-10 WO PCT/US1990/002655 patent/WO1990014363A1/en not_active Ceased
- 1990-05-18 DK DK90305433T patent/DK0398753T3/da active
- 1990-05-18 CA CA002017166A patent/CA2017166C/en not_active Expired - Lifetime
- 1990-05-18 ES ES90305433T patent/ES2123495T3/es not_active Expired - Lifetime
- 1990-05-18 DE DE69032609T patent/DE69032609T2/de not_active Expired - Lifetime
- 1990-05-18 EP EP94109856A patent/EP0623676A1/de not_active Withdrawn
- 1990-05-18 AT AT90305433T patent/ATE170560T1/de not_active IP Right Cessation
- 1990-05-18 SG SG1996001526A patent/SG43824A1/en unknown
- 1990-05-18 EP EP90305433A patent/EP0398753B1/de not_active Expired - Lifetime
- 1990-06-18 SG SG1996001440A patent/SG48766A1/en unknown
-
1995
- 1995-03-02 US US08/397,320 patent/US6946264B1/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| SG43824A1 (en) | 1997-11-14 |
| EP0398753A2 (de) | 1990-11-22 |
| AU648505B2 (en) | 1994-04-28 |
| DK0398753T3 (da) | 1999-02-01 |
| US6946264B1 (en) | 2005-09-20 |
| HK1008342A1 (en) | 1999-05-07 |
| SG48766A1 (en) | 1998-05-18 |
| EP0623676A1 (de) | 1994-11-09 |
| CA2017166C (en) | 2003-10-21 |
| AU5638890A (en) | 1990-12-18 |
| EP0398753B1 (de) | 1998-09-02 |
| JP2877509B2 (ja) | 1999-03-31 |
| DE69032609D1 (de) | 1998-10-08 |
| ES2123495T3 (es) | 1999-01-16 |
| EP0398753A3 (de) | 1991-10-16 |
| WO1990014363A1 (en) | 1990-11-29 |
| JPH04500683A (ja) | 1992-02-06 |
| CA2017166A1 (en) | 1990-11-19 |
| DE69032609T2 (de) | 1999-05-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE170560T1 (de) | Metalloproteinase-inhibitoren | |
| NO914092L (no) | Nye mercaptoacetylamid-derivater som er anvendbare som inhibitorer for enkefalinase og ace | |
| AR227063A1 (es) | Procedimiento para la produccion de nuevos acidos 7-amino-1-ciclopropil-4-oxo-1,4-dihidro-(1,6-y 1,8-naftiridina o quinolina)-3-carboxilicos | |
| NO923744L (no) | Nye 2-substituerte indan-2-mercaptoacetylamidderivater anvendbare som inhibitorer av enkefalinase og ace | |
| DE68929460D1 (de) | Substituierte Phenylpyrimidine Derivate, für die Behandlung oder Prevention von ZNS-Erkrankungen | |
| ES2138956T3 (es) | Imidazoquinoxalinonas, sus analogos aza y procedimiento para su preparacion. | |
| ITMI921909A0 (it) | Procedimento per il rinnovo di un binario nonche' complesso di macchine | |
| IT8323617A0 (it) | Composizione a base di resina sintetica e processo per la suaproduzione. | |
| IT8820392A0 (it) | Macchina per il ricambio di traversine. | |
| FI904734A0 (fi) | Anordning foer maetning av tryckdifferens. | |
| FI904735A0 (fi) | Anordning foer maetning av tryckdifferens. | |
| DE3764724D1 (de) | 2-phenylbenzoxepin-derivat. | |
| IT1242028B (it) | Apparecchiatura per la produzione di sigarette. | |
| DK345588D0 (da) | 1,2-diketo-derivater til anvendelse som renin-inhibitorer | |
| IT1184730B (it) | Procedimento per produrre difenilammine oppure n,n'-difenil-fenilendiammine | |
| FI864246A0 (fi) | N-substituerade 3-piperidin- eller 3-pyridinkarboxylsyror samt deras derivat. | |
| IT8821725A0 (it) | Elemento costruttivo, nonche' metodo per la produzione dello stesso. | |
| IT1098853B (it) | Processo per la produzione di 1,1,1,2-tetrafluoroetano | |
| IT8520246A0 (it) | Procedimento stereocontrollato per la produzione di acetossiazetidinone. | |
| ES2042726T3 (es) | Beta-alquilmelatoninas. | |
| IT1204414B (it) | Analoghi di amminoprostaglandine 5,6-epossi-7-ossabicicloeptano sostituite,utili nel trattamento di trombosi | |
| IT8348537A0 (it) | Procedimento per la produzione di 1,2-dicloroetano | |
| DK281186D0 (da) | 1,4 dihydropyridinderivater, der er nyttige til behandling af cardiovaskulaere lidelser | |
| PT87738A (pt) | Process for the preparation of novel thiophen compounds | |
| NO921706D0 (no) | Nye 2-merkaptomethylen-tetrahydronafthalen- og indan-2-carboxamidderivater som enkefalinaseinhibitorer |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| EELA | Cancelled due to lapse of time |